Research team calling out for volunteers for COVID-19 booster trial in Doncaster

Grounded Research, the research team at Rotherham Doncaster and South Humber NHS Foundation Trust (RDaSH), has been selected to be part of an international COVID-19 Booster Trial, and the team are once again calling out to the public in Doncaster for their support.

Thursday, 25th November 2021, 11:02 am

Dr Adrian Phillipson, leading the trial for Grounded Research, said: “Through participating in COVID research studies volunteers have made the vaccine programme possible. However, as we all know, the pandemic is not over and we still need volunteers to come forward to take part in vital research, which will help us plan across the UK and beyond.”

The new study is to determine the effects of a booster dose for COVID-19, to assess if a booster injection can increase and broaden the immune response against the different variants of COVID that cause the disease in participants who have previously been fully vaccinated.

Dr Adrian Phillipson continued: “As more of the population become fully vaccinated, this sort of research continues to strengthen our understanding of how we can help protect everyone against coronavirus in the future. It will make a real difference.”

Sign up to our daily newsletter

The i newsletter cut through the noise

Vital research is still needed, and participation is key to the success

Read More

Read More
Children in Doncaster should stay off school if someone in their house tests pos...

The study is open to adults aged 18-years-old and above. A broad range of people may be included, from those who are healthy to those with health problems that put them at risk for complications due to COVID-19.

Needed are 70 volunteers, adults vaccinated four to ten months ago with the Astra Zeneca vaccine. The trial will be run in the Grounded Research Hub in the Tickhill Road Hospital in Balby.

Participants will be asked to attend a minimum of six study visits, and their health will be monitored for 12 months.

RDaSH Executive Medical Director, Dr Navjot Ahluwalia, said: ““By looking at the safety and effectiveness of the booster vaccine, we hope that researchers and participants can help add another option to our current portfolio of vaccines - giving us a broader range of vaccines and helping us to reinforce supply as we look to boost immunity in the population in the future.”

For more information about the study and how to register to take part please follow this link COVID-19 Booster Vaccine Clinical Study | Sanofi Studies (centerwatch.com)